USL311 is primarily utilized in the field of medicinal chemistry, particularly in the development of therapeutic agents targeting specific biological pathways. It has shown potential as a modulator of certain protein interactions, making it a candidate for research in treating diseases where these proteins play a critical role. Its application extends to preclinical studies, where it is used to understand the efficacy and safety profile of new drug candidates. Additionally, USL311 is explored for its potential in enhancing the selectivity and potency of pharmaceuticals aimed at complex disorders. Researchers are also investigating its role in combination therapies to improve treatment outcomes in challenging medical conditions.